Chronic tissue inflammation and metabolic disease

Obesity is the most common cause of insulin resistance, and the current obesity epidemic is driving a parallel rise in the incidence of T2DM. It is now widely recognized that chronic, subacute tissue inflammation is a major etiologic component of the pathogenesis of insulin resistance and metabolic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Genes & development Ročník 35; číslo 5-6; s. 307
Hlavní autoři: Lee, Yun Sok, Olefsky, Jerrold
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States 01.03.2021
Témata:
metaflammation
β-cell dysfunction
immunometabolism
inflammation
glucose intolerance
macrophage
insulin resistance
ISSN:1549-5477, 1549-5477
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Obesity is the most common cause of insulin resistance, and the current obesity epidemic is driving a parallel rise in the incidence of T2DM. It is now widely recognized that chronic, subacute tissue inflammation is a major etiologic component of the pathogenesis of insulin resistance and metabolic dysfunction in obesity. Here, we summarize recent advances in our understanding of immunometabolism. We discuss the characteristics of chronic inflammation in the major metabolic tissues and how obesity triggers these events, including a focus on the role of adipose tissue hypoxia and macrophage-derived exosomes. Last, we also review current and potential new therapeutic strategies based on immunomodulation.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1549-5477
1549-5477
DOI:10.1101/gad.346312.120